Skip to content
The Policy VaultThe Policy Vault

LumiganMedica

reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Preferred products

  • generic latanoprost ophthalmic solution
  • generic bimatoprost 0.03% ophthalmic solution
  • generic travoprost 0.004% ophthalmic solution

Initial criteria

  • Patient has tried one Step 1 Product (generic latanoprost ophthalmic solution, generic bimatoprost 0.03% ophthalmic solution, or generic travoprost 0.004% ophthalmic solution)
  • OR patient has a known benzalkonium chloride (BAK) sensitivity AND a known sensitivity to other ophthalmic preservatives (for Xelpros or Zioptan only)

Reauthorization criteria

  • Same criteria as initial approval

Approval duration

1 year